Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMT1 | P30419 | 5/20 | 0.50 |
| ▸ | NMT2 | O60551 | 4/20 | 0.50 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.45 |
| ▸ | TLR2 | O60603 | 1/20 | 0.45 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.42 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.42 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.42 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.42 |
| ▸ | TFPI | P10646 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10740541 | 1.00 | NMT1 (0.50) | NMT1NMT2OPRL1TLR2NOD1 | |
| SCHEMBL10745610 | 0.94 | NMT1 (0.51) | NMT1NMT2OPRL1TLR2GRIN2D | |
| SCHEMBL10745622 | 0.94 | NMT1 (0.51) | NMT1NMT2OPRL1TLR2GRIN2D | |
| SCHEMBL29769744 | 0.93 | NMT1 (0.54) | NMT1NMT2OPRL1TLR2NOD1 | |
| SCHEMBL29727648 | 0.91 | NMT1 (0.45) | NMT1NMT2OPRL1TLR2 | |
| SCHEMBL29727669 | 0.88 | OPRL1 (0.49) | NMT1NMT2OPRL1GRIN2DGRIN3B | |
| Trifluoroacetic Acid SCHEMBL10742132 | 0.87 | OPRL1 (0.46) | NMT1NMT2OPRL1TLR2GRIN2D | |
| SCHEMBL10747201 | 0.86 | OPRL1 (0.55) | OPRL1TFPI | |
| SCHEMBL10747193 | 0.86 | OPRL1 (0.55) | OPRL1TFPI | |
| SCHEMBL31230537 | 0.85 | NOD1 (0.49) | NMT1NMT2NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4013769-A2 | ZINC ACTIVATED THYMULIN AND METHODS OF PREPARATION AND ADMINISTRATION | Cytolyf Therapeutics LLC (US) | 2022-06-22 | — | — | EP | claimed |
| EP-0232435-A2 | Serum thymic factor peptide analogs and a process for the preparation thereof | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu (CS) | 1987-08-19 | — | — | EP | claimed |